TrialCanadian respiratory journal

Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial).

Paul K Keith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.